Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
161 studies found for:    "juvenile idiopathic arthritis" OR "Arthritis, Juvenile Rheumatoid"
Show Display Options
Rank Status Study
1 Recruiting Pharmacovigilance in Juvenile Idiopathic Arthritis Patients Treated With Biologic Agents and/or Methotrexate
Condition: Juvenile Idiopathic Arthritis
Intervention:
2 Active, not recruiting Effective Dose of Etanercept in Patients Treated for Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Genetic: Blood test
3 Completed
Has Results
Safety and Effectiveness of Rilonacept for Treating Systemic Juvenile Idiopathic Arthritis in Children and Young Adults
Condition: Juvenile Idiopathic Arthritis
Intervention: Biological: Rilonacept
4 Completed
Has Results
Active Juvenile Idiopathic Arthritis (JIA) Compassionate Use
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: Adalimumab
5 Recruiting Massage Therapy in Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Interventions: Other: Massage therapy;   Other: Standard care
6 Unknown  Cost of Care for Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention:
7 Unknown  Study of Antibodies to Anti-TNF Agents in Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention:
8 Recruiting Oxidation Rates of the Different Substrates During Exercise in Children and Adolescents With Juvenile Idiopathic Arthritis. Case-control Study and Cases Treated / Cases Not Treated With Anti-TNFα
Condition: Juvenile Idiopathic Arthritis
Intervention: Other: anti-TNFα
9 Completed Effect of Whole Body Vibration Therapy in Children With Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Device: Galileo (whole body vibration (WBV) therapy)
10 Terminated
Has Results
A Study of the Safety and Efficacy of CNTO 148 (Golimumab) in Children With Juvenile Idiopathic Arthritis (JIA) and Multiple Joint Involvement Who Have Poor Response to Methotrexate (GO KIDS)
Condition: Juvenile Idiopathic Arthritis
Interventions: Drug: CNTO 148 (Golimumab);   Drug: Placebo;   Drug: Methotrexate
11 Completed Aggressive Combination Drug Therapy in Very Early Polyarticular Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Interventions: Drug: Infliximab plus methotrexate;   Drug: Combination of DMARDs;   Drug: Methotrexate alone
12 Unknown  Sleep Patterns in Children With and Without Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Behavioral: comparison of types of sleep disordered breathing
13 Recruiting An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention:
14 Unknown  Efficacy Study of Leflunomide to Treat Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: Leflunomide
15 Unknown  Withdrawal of Etanercept After Successful Treatment of Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: etanercept
16 Recruiting Long-Term Safety Study Of Tofacinib In Patients With Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: Tofacitinib
17 Completed Efficacy of Web-based Pain Self-management for Adolescents With Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Interventions: Behavioral: Web-based coping skills training;   Behavioral: Online disease education
18 Active, not recruiting Virtual Peer-to-Peer (VP2P) Support Mentoring for Juvenile Idiopathic Arthritis (JIA): A Pilot RCT
Condition: Juvenile Idiopathic Arthritis
Intervention: Behavioral: Virtual Peer-to-Peer Support Mentoring
19 Completed
Has Results
Open-label Safety and Pharmacokinetic Study of DUEXIS® (Ibuprofen and Famotidine) Tablets in Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: 800 mg ibuprofen/26.6 mg famotidine
20 Completed
Has Results
Pharmacokinetics Of CP-690,550 In Pediatric Patients With Juvenile Idiopathic Arthritis (JIA)
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: CP-690,550

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.